This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: G.d. Searle & Company. Active years: 1986-1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1986-1988
Title: Geoffrey Kneen: Innovator in Hydroxamic Acid Based Collagenase Inhibitors
Introduction
Geoffrey Kneen is a notable inventor based in West Wycombe, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of hydroxamic acid based collagenase inhibitors. With a total of 2 patents to his name, Kneen's work is paving the way for advancements in the treatment of collagenase induced diseases.
Latest Patents
Kneen's latest patents focus on a novel class of hydroxamic acid based collagenase inhibitor derivatives. These disclosures relate to pharmaceutical compositions that contain such compounds and their use in treating diseases caused by collagenase. His innovative approach aims to provide effective solutions for conditions that arise from collagenase activity.
Career Highlights
Throughout his career, Geoffrey Kneen has been associated with G.D. Searle & Company, where he has been instrumental in research and development. His expertise in the field has led to the creation of impactful pharmaceutical products that address critical health issues.
Collaborations
Kneen has worked alongside notable colleagues such as Jonathan P. Dickens and David K. Donald. Their collaborative efforts have contributed to the advancement of research in the pharmaceutical industry.
Conclusion
Geoffrey Kneen's innovative work in hydroxamic acid based collagenase inhibitors showcases his dedication to improving healthcare solutions. His contributions are significant in the ongoing fight against collagenase induced diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile